Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mink Therapeutics

Clinical trials sponsored by Mink Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental immune therapy aims to reduce deaths in severe pneumonia Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

Experimental immune therapy aims to reduce deaths in severe pneumonia

Disease control Recruiting now

This study tests whether a single dose of an experimental immune cell therapy called agenT-797, given alongside standard care, can lower the risk of death in adults with severe pneumonia and breathing failure. About 90 people in intensive care will receive either agenT-797 or a p…

Phase 2 • Sponsor: MiNK Therapeutics • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC